While in some types of tumor the levels of this protein have been shown to inversely correlate with pancreatic cancer cell growth [69], other studies show that MnSOD is reduced in many types of cancer [70], including breast cancer [71, 72], pancreatic cancer [73], and ovarian cancer [74]. This evidence concerns the gene SOD2 and familial pancreatic carcinoma.